Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,173 shares at $295.38 ($1.2M) on 2023-02-22, disclosed to the SEC on 2023-02-24.
Seasonal sale ($1.2M) by EVP, COO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $291.84 | 129 | $38K | 3.1% |
| 2 | $292.86 | 300 | $88K | 7.2% |
| 3 | $294.29 | 1,378 | $406K | 33.0% |
| 4 | $294.29 | 1,378 | $406K | 33.0% |
| 5 | $295.38 | 394 | $116K | 9.5% |
| 6 | $295.38 | 394 |
| $116K |
| 9.5% |
| 7 | $296.31 | 200 | $59K | 4.8% |
| Total | $294.41 avg | 4,173 | $1.2M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |